Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma

Status:
Completed

Trial end date:
2009-03-01

Target enrollment:

Participant gender:

The purpose of this study is to compare once and twice daily GW685698 in asthma

Phase 2

GlaxoSmithKline